BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18270398)

  • 1. Vitamin D and cancer.
    Ali MM; Vaidya V
    J Cancer Res Ther; 2007; 3(4):225-30. PubMed ID: 18270398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the potential of vitamin D to prevent cancer.
    Ingraham BA; Bragdon B; Nohe A
    Curr Med Res Opin; 2008 Jan; 24(1):139-49. PubMed ID: 18034918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D, sunlight, and the epidemiology of prostate cancer.
    Schwartz GG
    Anticancer Agents Med Chem; 2013 Jan; 13(1):45-57. PubMed ID: 23094920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.
    Moukayed M; Grant WB
    Rev Endocr Metab Disord; 2017 Jun; 18(2):167-182. PubMed ID: 28213657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamins as hormones.
    Reichrath J; Lehmann B; Carlberg C; Varani J; Zouboulis CC
    Horm Metab Res; 2007 Feb; 39(2):71-84. PubMed ID: 17326003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.
    Hedlund TE; Moffatt KA; Miller GJ
    J Steroid Biochem Mol Biol; 1996 Jun; 58(3):277-88. PubMed ID: 8836163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and prostate cancer risk: a review of the epidemiological literature.
    Gupta D; Lammersfeld CA; Trukova K; Lis CG
    Prostate Cancer Prostatic Dis; 2009; 12(3):215-26. PubMed ID: 19350051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
    Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D, Cancer Risk, and Mortality.
    Tagliabue E; Raimondi S; Gandini S
    Adv Food Nutr Res; 2015; 75():1-52. PubMed ID: 26319903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium, vitamin D and cancer.
    Peterlik M; Grant WB; Cross HS
    Anticancer Res; 2009 Sep; 29(9):3687-98. PubMed ID: 19667166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and the epidemiology of prostate cancer.
    Schwartz GG
    Semin Dial; 2005; 18(4):276-89. PubMed ID: 16076349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Vitamin D insensitive prostate cancer cells.
    Alagbala AA; Moser MT; Johnson CS; Trump DL; Foster BA
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):712-6. PubMed ID: 17280828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Importance of vitamin D in cancer management.
    Qadir MI; Rasul A; Akash MSH; Irfan M; Ibrahim MR; Hussain SB
    Pak J Pharm Sci; 2020 Jul; 33(4):1711-1718. PubMed ID: 33583806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pleiotropic actions of vitamin D.
    Lin R; White JH
    Bioessays; 2004 Jan; 26(1):21-8. PubMed ID: 14696037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.